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Abstract: 
GST (glutathione S-transferases) are a family of detoxification enzymes that catalyze the conjugation of reduced GSH 
(glutathione) to xenobiotic (endogenous electrophilic) compounds. GST from Wb (Wuchereria bancrofti) and Bm (Brugia 
malayi) are significantly different from human GST in sequence and structure. Thus, Wb-GST and Bm-GST are potential 
chemotherapeutic targets for anti-filarial treatment. Comparison of modeled Wb and Bm GST with human GST show structural 
difference between them. Analysis of the active site residues for the binding of electrophilic co-substrates provides insight 
towards the design of parasite specific GST inhibitors. 
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Background: 
Lymphatic Filariais is an infectious disease that causes 
serious social and economic burden. [1, 2] Filariasis is 
caused by worms, Wuchereria bancrofti (Wb), Brugia 
malayi (Bm) and Brugia timori belonging to the order 
"Filariidae". The worm is transmitted to man by different 
mosquito species. Wb is responsible for 90% of the cases 
worldwide followed by Bm  which is  confined to some 
regions of Southeast and Eastern Asia. [3] Filarial disease 
management requires effective anti-filarial inhibitors. [4] 
Current anti-filarial drug discovery aims towards the 
development of safe and effective
 macrofilaricide (a drug 
targeting adult filarial worms). GST (glutathione S-
transferases) are a family of detoxification enzymes that 
catalyze the conjugation of reduced GSH (glutathione) to 
xenobiotic (endogenous electrophilic) compounds. They 
protect tissues against oxidative damage and are involved 
in the intracellular transport of hydrophobic substrates such 
as non-catalytic carrier proteins. [5] The worm and human 
GST are structurally different. [6] Hence, the worm GST is 
a promising chemotherapeutic target. Previous studies 
show defense mechanisms evolved by the worm against the 
host immune system. [7] The worm develops the capacity 
to neutralize host-derived reactive oxygen species (H2O2, 
super oxide radicals, hydroxyl ions, and nitric oxide). [8] 
The worm GST provides the defense against electrophilic 
and oxidative damage. [9] Therefore, it is our interest to 
study the structural features of GST from human and worm 
using homology modeling techniques. Here, we describe 
the structural differences between human and worm GST 
towards the design of potential inhibitors as anti-filarial 
drugs.   
 
Methodology: 
The protein sequences (208 residues long) for Wb-GST 
(Q86LL8) and Bm-GST (O02636) were obtained from the 
Swiss-Prot Database. The protein databank (PDB) contains 
several GST structures from different species 
((Schistosoma japonicum (PDBID: IM9A), Fasciola 
hepatica  (PDBID: IFHE),  Sus scrofa (PDBID: 2GSR), 
Homo sapiens (PDBID: 19GS)). However, structures for 
Wb  GST and Bm GST were not available. Sequence 
analysis using PSI-BLAST show Wb  GST and Bm GST 
having 42% and 41% sequence identity (highest homology 
compared to other known structures) with Sus scrofa, 
respectively. Therefore, we used the structure of Sus scrofa 
GST (PDB: 2GSR) as template for building homology 
models for Wb GST and Bm GST using MOE (molecular 
operating environment), an automated molecular modeling 
tool.  [10] The predicted models were evaluated for 
geometry, stereo-chemistry and energy distributions. The 
models were systematically analyzed using WHATIF [11] 
for various structural properties. The model was also 
evaluated using the model assessment procedure described 
elsewhere by Luthy, Bowie and Eisenberg. [12] The Bm-
GST predicted model contains 96.6% residues in the 
favored regions and 99.5% residues in the allowed regions 
of the Ramachandran Plot. Similarly, Wb-GST predicted 
model contains 97.1% residues in the favored regions and 
99.0% residues in the allowed regions of the 
Ramachandran Plot. We then superimposed the predicted 
models of Wb GST and Bm GST with the crystal structure 
of human GST for the calculation of RMSD (root mean 
square deviation) of the Cα backbone atoms of all residues 
in GST. [13] 
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Results and Discussion:  
An active GST is a homodimer of a 208 residue long 
monomer consisting of two domains (smaller α/β domain 
and larger α domain). The N-terminal small domain 
(residues 1 to 74) is an α/β structure [14] with the folding 
topology βαβαββα arranged in the order β2, β1,β3 and β4 
with β3 anti-parallel to the others, forming a regular β-sheet 
with a right-handed twist surrounded by three α-helices. 
The C terminal, large domain 2 (82-208 residues) is α-
helical. GST does not contain the typical α-class α-9 helix 
which distinguishes between α and π-class enzymes. The 
residues that interface the two βαβ and ββα motifs are 
Trp 38, Phe 8, Val 33, Cys 47, Leu 52 and Leu 43 in human 
π GST. In Wb-GST and Bm-GST the residues Val 33, Cys 
47, and Leu 43 are replaced by Ile 38, Phe 47 and Met 43.  
The human π-class GST recognizes GSH by an induced-fit 
mechanism [15] and the apo-enzyme helix α-2 is flexible. 
[16] The active site residues (Tyr 49 and Cys 47) binding to 
GSH are not conserved in Wb-GST and Bm-GST and they 
are replaced by Phe 49 and Phe 47. The human GST forms 
a disulphide bond between Cys 47 and Cys 101 under 
oxidized conditions and thus making the enzyme inactive. 
[17, 18, 19] In Wb-GST  and Bm-GST the Cys residues 
(Cys47 and Cys101) are replaced  by Phe and Thr, 
respectively. The effect of this mutation in Wb-GST and 
Bm-GST is not known. A previous study shows the 
inactivation of GST and not able to bind GSH. [20] 
Therefore, it is important to document the residue level 
mutations between human, Bm and Wb GST sequences and 
their significance in 3D structures. 
 
Residue Positions  Human  Wb  Bm 
008  Y Y Y 
010 V  I  I 
013 R  L  L 
035  V A A 
101 C  T  T 
104 I  A  T 
108  Y Y Y 
205  G G G 
Table 1: Residue changes between human, Bm and Wb GST is shown. These residues are involved in the formation of H-site. 
The sequence residue positions are with respect to the human GST sequence.  
 
Residue Positions  Human     Wb       Bm 
07  Y Y Y 
12  G G G 
13 R  L  L 
38  W W W 
44  K K K 
49 Y  F  F 
51  Q Q Q 
52  L L L 
53  P P P 
64  Q Q Q 
65  S S S 
71  H H H 
97 E  R  R 
98  D D D 
Table 2: Residue changes between human, Bm and Wb GST is shown. These residues are involved in the formation of G-site. 
The sequence residue positions are with respect to the human GST sequence.  
 
The residues involved in the formation of H-site (Xeno-
biotic binding site) binding pocket are shown in the Table 1 
and the residues involved in the formation of G-site (GSH 
binding site) binding pocket are given in Table 2. A further 
understanding of residue changes in H and G-site between 
human, Bm and Wb GST is critical. Tyr 108 in H site is 
known to enhance GSH binding [19] and this residue is 
conserved in all π-class GSTs. The hydrogen bonding 
interaction between the hydroxyl group of Tyr 108 and the 
amide nitrogen of Gly 204 is also been observed in mouse, 
pig and human π-class structures. [14] A comprehensive 
understanding of residue mutation at the H and G sites in 
human, Bm and Wb will provide insight towards the design 
of an GST inhibitor specifically for Bm and Wb. 
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Conclusion: 
DEC  (Diethyl carbamazine) is the only drug that is 
commonly used for Filariasis control. Therefore, it is 
important to design effective anti-filarial drugs. The 
comparison of modeled Wb and Bm GST structures with 
human GST structure provide insights towards the design 
of GST inhibitors. This study also demonstrates the effect 
of mutations towards function among homologous 
sequences. 
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